COVID-19 rapid test TRFIA

IgGIgMSARS-COV-2

IgM is the first antibody to appear in the acute infection stage caused by pathogens such as SARS CoV-2, and can normally be detected 3 days after the onset of symptoms, IgG is produced in the middle or later stage of the infection but provides long-term protection. In the latest 7th edition of the Diagnosis and Treatment Guideline on the Novel Coronavirus Disease (COVID-19), the SARS-CoV 2 IgG/IgM test is recommended as an aid in the diagnosis of the COVID-19. SARS-CoV-2 IgG/IgM Kit is used for rapid and accurate screening of the COVID-19, which helps identify suspected patients and reduce false negative rate. Rapid detection of recent SARS-CoV-2 infection ● In ONLY 12 minutes ● ONE-STEP operation ● Single cartridge, NO additional buffers ● TRFIA Europium particles displays Clear and Bright results ● Dual capturing antigens (S and N) enhanced sensitivity ● Important complement to PCR detection in COVID-19 diagnosis